Clinical Orthopaedics and Related Research®

, Volume 468, Issue 3, pp 834–845

Results of 32 Allograft-prosthesis Composite Reconstructions of the Proximal Femur

  • David J. Biau
  • Frédérique Larousserie
  • Fabrice Thévenin
  • Sophie Piperno-Neumann
  • Philippe Anract
Clinical Research

Abstract

The use of allograft-prosthesis composites for reconstruction after bone tumor resection at the proximal femur has generated considerable interest since the mid1980s on the basis that their use would improve function and survival, and restore bone stock. Although functional improvement has been documented, it is unknown whether these composites survive long periods and whether they restore bone stock. We therefore determined long-term allograft-prosthesis composite survival, identified major complications that led to revision, and determined whether allograft bone stock could be spared at the time of revision. We also compared the radiographic appearance of allografts sterilized by gamma radiation and fresh-frozen allografts. We retrospectively reviewed 32 patients with bone malignancy in the proximal femur who underwent reconstruction with a cemented allograft-prosthesis composite. The allograft-prosthesis composite was a primary reconstruction for 23 patients and a revision procedure for nine. The minimum followup was 2 months (median, 68 months; range, 2–232 months). The cumulative incidence of revision for any reason was 14% at 5 years (95% confidence interval, 1%–28%) and 19% at 10 years (95% confidence interval, 3%–34%). Nine patients (28%) had revision of the reconstruction during followup; four of these patients had revision surgery for infection. Allografts sterilized by gamma radiation showed worse resorption than fresh-frozen allografts. Based on reported results, allograft-composite prostheses do not appear to improve survival compared with megaprostheses.

Level of Evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

References

  1. 1.
    Akkus O, Belaney RM, Das P. Free radical scavenging alleviates the biomechanical impairment of gamma radiation sterilized bone tissue. J Orthop Res. 2005;23:838–845.CrossRefPubMedGoogle Scholar
  2. 2.
    Akkus O, Rimnac CM. Fracture resistance of gamma radiation sterilized cortical bone allografts. J Orthop Res. 2001;19:927–934.CrossRefPubMedGoogle Scholar
  3. 3.
    American Society of Anesthesiologists. New classification of physical status. Newsletter of the American Society of Anesthesiologists. Anesthesiology. 1963;24:111.Google Scholar
  4. 4.
    Anract P, Coste J, Vastel L, Jeanrot C, Mascard E, Tomeno B. [Proximal femoral reconstruction with megaprosthesis versus allograft prosthesis composite: a comparative study of functional results, complications and longevity in 41 cases] [in French]. Rev Chir Orthop Reparatrice Appar Mot. 2000;86:278–288.PubMedGoogle Scholar
  5. 5.
    Biau DJ, Davis A, Vastel L, Tomeno B, Anract P. Function, disability, and health-related quality of life after allograft-prosthesis composite reconstructions of the proximal femur. J Surg Oncol. 2008;97:210–215.CrossRefPubMedGoogle Scholar
  6. 6.
    Biau DJ, Dumaine V, Babinet A, Tomeno B, Anract P. Allograft-prosthesis composites after bone tumor resection at the proximal tibia. Clin Orthop Relat Res. 2007;456:211–217.CrossRefPubMedGoogle Scholar
  7. 7.
    Biau DJ, Latouche A, Porcher R. Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate? Clin Orthop Relat Res. 2007;462:229–233.CrossRefPubMedGoogle Scholar
  8. 8.
    Bow EJ. Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. J Antimicrob Chemother. 1998;41(suppl D):1–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Chen WM, Chen TH, Huang CK, Chiang CC, Lo WH. Treatment of malignant bone tumours by extracorporeally irradiated autograft-prosthetic composite arthroplasty. J Bone Joint Surg Br. 2002;84:1156–1161.CrossRefPubMedGoogle Scholar
  10. 10.
    Clatworthy MG, Gross AE. The allograft prosthetic composite: when and how. Orthopedics. 2001;24:897–898.PubMedGoogle Scholar
  11. 11.
    Donati D, Colangeli M, Colangeli S, Di Bella C, Mercuri M. Allograft-prosthetic composite in the proximal tibia after bone tumor resection. Clin Orthop Relat Res. 2008;466:459–465.CrossRefPubMedGoogle Scholar
  12. 12.
    Donati D, Giacomini S, Gozzi E, Mercuri M. Proximal femur reconstruction by an allograft prosthesis composite. Clin Orthop Relat Res. 2002;394:192–200.CrossRefPubMedGoogle Scholar
  13. 13.
    Farid Y, Lin PP, Lewis VO, Yasko AW. Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res. 2006;442:223–229.CrossRefPubMedGoogle Scholar
  14. 14.
    Finstein JL, King JJ, Fox EJ, Ogilvie CM, Lackman RD. Bipolar proximal femoral replacement prostheses for musculoskeletal neoplasms. Clin Orthop Relat Res. 2007;459:66–75.CrossRefPubMedGoogle Scholar
  15. 15.
    Fletcher CDM, Unni KK, Merten SF (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.Google Scholar
  16. 16.
    Fox EJ, Hau MA, Gebhardt MC, Hornicek FJ, Tomford WW, Mankin HJ. Long-term followup of proximal femoral allografts. Clin Orthop Relat Res. 2002;397:106–113.CrossRefPubMedGoogle Scholar
  17. 17.
    Hanson PD, Warner C, Kofroth R, Osmond C, Bogdanske JJ, Kalscheur VL, Frassica FJ, Markel MD. Effect of intramedullary polymethylmethacrylate and autogenous cancellous bone on healing of frozen segmental allografts. J Orthop Res. 1998;16:285–292.CrossRefPubMedGoogle Scholar
  18. 18.
    Hejna MJ, Gitelis S. Allograft prosthetic composite replacement for bone tumors. Semin Surg Oncol. 1997;13:18–24.CrossRefPubMedGoogle Scholar
  19. 19.
    Hornicek FJ, Gebhardt MC, Tomford WW, Sorger JI, Zavatta M, Menzner JP, Mankin HJ. Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res. 2001;382:87–98.CrossRefPubMedGoogle Scholar
  20. 20.
    Jensen KL, Johnston JO. Proximal humeral reconstruction after excision of a primary sarcoma. Clin Orthop Relat Res. 1995;311:164–175.PubMedGoogle Scholar
  21. 21.
    Jeys LM, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am. 2005;87:842–849.CrossRefPubMedGoogle Scholar
  22. 22.
    Kabukcuoglu Y, Grimer RJ, Tillman RM, Carter SR. Endoprosthetic replacement for primary malignant tumors of the proximal femur. Clin Orthop Relat Res. 1999;358:8–14.CrossRefPubMedGoogle Scholar
  23. 23.
    Konishi T, Watanabe T, Kishimoto J, Nagawa H. Elective colon and rectal surgery differ in risk factors for wound infection: results of prospective surveillance. Ann Surg. 2006;244:758–763.CrossRefPubMedGoogle Scholar
  24. 24.
    Langlais F, Lambotte JC, Collin P, Thomazeau H. Long-term results of allograft composite total hip prostheses for tumors. Clin Orthop Relat Res. 2003;414:197–211.CrossRefPubMedGoogle Scholar
  25. 25.
    Langlais F, Tomeno B (eds). Limb Salvage: Major Reconstructions in Oncologic and Nontumoral Conditions. Heidelberg, Germany: Springer; 1991.Google Scholar
  26. 26.
    Lietman SA, Tomford WW, Gebhardt MC, Springfield DS, Mankin HJ. Complications of irradiated allografts in orthopaedic tumor surgery. Clin Orthop Relat Res. 2000;375:214–217.CrossRefPubMedGoogle Scholar
  27. 27.
    Liu JW, Chao LH, Su LH, Wang JW, Wang CJ. Experience with a bone bank operation and allograft bone infection in recipients at a medical centre in southern Taiwan. J Hosp Infect. 2002;50:293–297.CrossRefPubMedGoogle Scholar
  28. 28.
    Liu SA, Wong YK, Poon CK, Wang CC, Wang CP, Tung KC. Risk factors for wound infection after surgery in primary oral cavity cancer patients. Laryngoscope. 2007;117:166–171.CrossRefPubMedGoogle Scholar
  29. 29.
    Mankin HJ, Hornicek FJ, Raskin KA. Infection in massive bone allografts. Clin Orthop Relat Res. 2005;432:210–216.CrossRefPubMedGoogle Scholar
  30. 30.
    McGoveran BM, Davis AM, Gross AE, Bell RS. Evaluation of the allograft-prosthesis composite technique for proximal femoral reconstruction after resection of a primary bone tumour. Can J Surg. 1999;42:37–45.PubMedGoogle Scholar
  31. 31.
    Menendez LR, Ahlmann ER, Kermani C, Gotha H. Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop Relat Res. 2006;450:46–51.CrossRefPubMedGoogle Scholar
  32. 32.
    Mitchell EJ, Stawarz AM, Kayacan R, Rimnac CM. The effect of gamma radiation sterilization on the fatigue crack propagation resistance of human cortical bone. J Bone Joint Surg Am. 2004;86:2648–2657.PubMedGoogle Scholar
  33. 33.
    Morris CD, Sepkowitz K, Fonshell C, Margetson N, Eagan J, Miransky J, Boland PJ, Healey J. Prospective identification of risk factors for wound infection after lower extremity oncologic surgery. Ann Surg Oncol. 2003;10:778–782.CrossRefPubMedGoogle Scholar
  34. 34.
    Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204:1178–1187.CrossRefPubMedGoogle Scholar
  35. 35.
    Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VJ. Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 2008;207:326–335.CrossRefPubMedGoogle Scholar
  36. 36.
    Penel N, Yazdanpanah Y, Chauvet MP, Clisant S, Giard S, Neu JC, Lefebvre D, Fournier C, Bonneterre J. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol. 2007;96:124–129.CrossRefPubMedGoogle Scholar
  37. 37.
    Potter BK, Adams SC, Pitcher JD Jr, Malinin TI, Temple HT. Proximal humerus reconstructions for tumors. Clin Orthop Relat Res. 2009;467:1035–1041.CrossRefPubMedGoogle Scholar
  38. 38.
    R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2006. Available at: www.R-project.org. Accessed May 13, 2009.
  39. 39.
    Selek H, Basarir K, Yildiz Y, Saglik Y. Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur. J Arthroplasty. 2008;23:112–117.CrossRefPubMedGoogle Scholar
  40. 40.
    Straw RC, Powers BE, Withrow SJ, Cooper MF, Turner AS. The effect of intramedullary polymethylmethacrylate on healing of intercalary cortical allografts in a canine model. J Orthop Res. 1992;10:434–439.CrossRefPubMedGoogle Scholar
  41. 41.
    Unwin PS, Cannon SR, Grimer RJ, Kemp HB, Sneath RS, Walker PS. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg Br. 1996;78:5–13.PubMedGoogle Scholar
  42. 42.
    Zehr RJ, Enneking WF, Scarborough MT. Allograft-prosthesis composite versus megaprosthesis in proximal femoral reconstruction. Clin Orthop Relat Res. 1996;322:207–223.CrossRefPubMedGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2009

Authors and Affiliations

  • David J. Biau
    • 1
    • 2
  • Frédérique Larousserie
    • 3
  • Fabrice Thévenin
    • 4
  • Sophie Piperno-Neumann
    • 5
  • Philippe Anract
    • 1
  1. 1.Department of Orthopaedic Surgery, Hôpital CochinUniversité Paris DescartesParis Cedex 14France
  2. 2.Department of Biostatistics and Clinical EpidemiologyHôpital Saint Louis, INSERM–UMR-S 717, Université Paris Diderot, AP-HPParisFrance
  3. 3.Department of PathologyHôpital Cochin, Université Paris Descartes, AP-HPParisFrance
  4. 4.Department of RadiologyHôpital Cochin, Université Paris Descartes, AP-HPParisFrance
  5. 5.Department of OncologyInstitut CurieParisFrance

Personalised recommendations